This compilation includes all of our research to-date on the coronavirus. High frequency charts on infection, mortality, economic and market data are updated as data becomes available, usually on a daily basis.
What’s new: Early tracking of variants and vaccine efficacy (Section 1); Vaccination update by country and US state (Section 1); Reinfection risks in previously infected populations (Section 4).
Our research to-date on the coronavirus: |
- Early tracking of variants and vaccine efficacy
- Where does herd immunity kick in?
- Vaccination update by country and US state
- How mRNA vaccines, vector vaccines and traditional vaccine types work
2. COVID global infection, hospitalization and mortality tracker
- Commentary and charts on the latest COVID trends by country and region
- Global and regional snapshots, comparisons of largest countries and US states
- How lethal is COVID, and for whom?
3. COVID tracker: countries and states
- Country and state specific charts on Infection, hospitalization and mortality
4. COVID: reinfection, antibodies, T-cell immune memory and survivor impacts
- COVID health impacts on survivors
- How virus testing and antibody testing work
- Pre-existing T-cell immune memory and COVID
- The issue of falling antibody levels in convalescing patients
- The latest news on anti-virals, monoclonal antibodies, convalescent plasma and corticosteroids
5. US spending, mobility, and production tracker
- High frequency tracking (manufacturing, retail, air travel, geolocation, oil, hotels, housing, etc.)
- Office utilization rates and mobility
- Real time credit and debit spending data
1. The US reopens: tracking US citizens and consumers
- High frequency recovery tracking (mobility, manufacturing, retail, air travel, geolocation, oil, hotels, housing, etc.)
- Real time credit and debit spending data
2. COVID global infection, hospitalization and mortality tracker
- Global COVID infection snapshot (trends, declines from peak levels, threshold levels)
- US hotspot tracking: infections, hospitalizations, mortality, testing and doctor visits
- Infection and mortality time series by country
3. COVID drug development (vaccines, antivirals, mAbs, steroids and blood thinners)
- What we know on the Pfizer/BioNTech vaccine news
- The latest news on anti-virals, vaccines, monoclonal antibodies, convalescent plasma and corticosteroids
- Potential benefits of anticoagulants, statins and ACE inhibitors for infected patients
- The latest news on anti-virals, vaccines, monoclonal antibodies, convalescent plasma and corticosteroids
- Potential benefits of anticoagulants, statins and ACE inhibitors for infected patients
5. COVID: testing for the virus and for antibodies, T-cell immune memory and survivor impacts
- How virus testing and antibody testing work
- Latest regional serology results and implications for higher levels of immunity
- Pre-existing T-cell immune memory and COVID
- The issue of falling antibody levels in convalescing patients
- COVID health impacts on survivors
6. Detailed virus reports by state
- One-page reports on each state with charts on infections, hospitalizations, mortality, testing levels, positive test rates, hospital bed/ICU utilization rates and doctor visit indicators
This compilation incorporates research and feedback from the Johns Hopkins University Center for Health Security, Harvard Medical School, the University of Toronto Dalla Lana School of Public Health, Washington University Biomedical Sciences Department, the La Jolla Institute for Immunology, the Imperial College of London Department of Infectious Disease Epidemiology and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
0903c02a8283f910
